Erektil'naya disfunktsiya pri zabolevaniyakh tsentral'noy nervnoy sistemy
- Autores: Popov S.V1
-
Afiliações:
- Edição: Nº 19 (2014)
- Páginas: 74-79
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287553
- ID: 287553
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
In neurological patients, erectile dysfunction (ED) develops as a consequence of both central nervous system disorders and psychogenic causes. 10-19% of organic erectile dysfunction has neurogenic nature. Traumatic brain injury, stroke, Parkinson's disease and multiple sclerosis often lead to the development of ED, significantly reducing the quality of life of these patients. Erectile dysfunction in neurological patients is often combined with depression, decreased libido, ejaculation and orgasm disorders. The variety of drugs used for the correction of neurogenic ED allows to individualize the therapy.
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Bibliografia
- Глыбочко П.В., Аляев Ю.Г., Чалый М.Е., Ахвледиани Н.Д. Половые расстройства у мужчин. М., 2012. 112 с.
- Мазо Е.Б., Гамидов С.И., Иремашвили В.В. Эректильная дисфункция. М., 2008. 240 с.
- Пушкарь Д.Ю., Юдовский С.О., Тевлин К.П. Консервативное лечение эректильной дисфункции: современные возможности медикаментозной терапии. Фарматека. 2003; 15(78): 1-4.
- Крупин В.Н., Белова А.Н. Нейроурология. М., 2005. 464 с.
- Мужские болезни. Под ред. А.А. Камалова, Н.А. Лопаткина. М., 2008. 320 с.
- Шварц П.Г. Нарушения половой функции при ранних клинических формах сосудистых заболеваний головного мозга. Ранние клинические формы сосудистых заболеваний головного мозга / Под ред. Л.С. Манвелова, А.С. Кадыкова. М., 2014; 212-35.
- Corrigan J.D., Selassie A.W., Orman J.A. The epidemiology of traumatic brain injury. J. Head Trauma Rehabil. 2010; 25(2): 72-80.
- Moreno J.A., et al. Sexuality after traumatic brain injury: A critical review. Neuro Rehabilitation. 2013; 32(1): 69-85.
- Arango-Lasprilla J.C., et al. Predictors of marital stability 2 years following traumatic brain injury. J. Brain Inj. 2008; 22(7-8): 565-74.
- Кочетков В.Д. Неврологические аспекты импотенции. М., 1968; 280 с.
- Rees P.M., Fowler C.J., Maas C.P. Sexual function in men and women with neurological disorders. Lancet. 2007; 369(9560): 512-25.
- Dolberg O.T., Klag E., Gross Y., Schreiber S. Relief of serotonin selective reuptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury. Psychopharmacology (Berl). 2002; 161(4): 404-7.
- Верещагин Н.В., Пирадов М.А., Суслина З.А. Инсульт. М., 2002; 207 с.
- Buzzelli S. et al. Psychological and Medical Aspects of Sexuality Following Stroke. Sexuality and Disability. 1997; 15(4): 261-70.
- Monga T.N. et al. Sexual dysfunction in stroke patients. Arch. Phys. Med. Rehabil. 1986; 67: 19-22.
- Korpelainen J.T., Nieminen P., Myllyla V.V. Sexual functioning among stroke patients and their spouses. Stroke. 1999; 30(4): 715-19.
- Thompson I.M. et al. Erectile dysfunction and subsequent cardiovascular disease. JAMA. 2005; 294: 2996-3002.
- Akinpelu A.O. et al. Sexual dysfunction in Nigerian stroke survivors. Afr Health Sci. 2013; 13(3): 639-45.
- Камалов А.А., Абоян И.А., Ситдыкова М.Э. и др. Терапия ускоренного семяизвержения биологически активной добавкой к пище НейроДоз: результаты мультицентрового клинического нерандомизированного исследования. Урология. 2013; 5: 37-42.
- Pryor J.L., Althof S.E., Steidle C. et al. Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation. J. Urol. 2005; 173(4): 201.
- Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А., Строева Д.Е. Хронобиологические аспекты применения комплекса НейроДоз у больных эректильной дисфункцией. Московский Уролог. 2014; 4: 24-5.
- Sakakibara R., et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton. Neurosci. 2001; 92(1-2): 76-85.
- Bronner G., et al. Sexual dysfunction in Parkinson's disease. J. Sex. Marital. Ther. 2004; 30(2): 95-105.
- Raffaele R., et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of sexual dysfunction in depressed patients with idiopathic Parkinson’s disease. Eur. Urol. 2002; 41(4): 382-86.
- Sakakibara R., et al. Bladder, bowel and sexual dysfunction in Parkinson's disease. Parkinsons Dis. 2011; 924605.
- Шмидт Т.Е., Яхно Н.Н. Рассеянный склероз. М., 2012. 272 с.
- Xiao Y., et al. Sildenafil citrate for erectile dysfunction in patients with multiple sclerosis. Cochrane Database Syst Rev. 2012; 18(4): CD00942.
- Lombardi G., et al. Efficacy and safety of tadalafil for erectile dysfunction in patients with multiple sclerosis. J. Sex. Med. 2010; 7(6): 2192-200.
- Ефремов Е.А. Эректильная дисфункция как полиэтиологический синдром. Дисс. докт.. мед. наук. М., 2011.
Arquivos suplementares
![](/img/style/loading.gif)